Uetikon am See, Switzerland

Marc Bloechlinger

This inventor holds 1 USPTO granted patent. Top assignee: Mettler-Toledo Ag. Active years: 2013.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Marc Bloechlinger

Introduction

Marc Bloechlinger is a notable inventor based in Uetikon am See, Switzerland. He has made significant contributions to the field of dosage-dispensing technology. His innovative approach has led to the development of a unique method that optimizes dosage-dispensing processes.

Latest Patents

Marc Bloechlinger holds a patent for a "Method of optimizing dosage-dispensing processes, and dosage-dispensing device." This patent outlines a method that examines flow parameters before the first dosage delivery. If a flow parameter is stored in the device's memory, it is utilized; otherwise, the user can request a flow parameter or it can be determined based on default settings. This method enhances the efficiency of dosage-dispensing programs and ensures accurate delivery.

Career Highlights

Marc is currently associated with Mettler-Toledo AG, a company renowned for its precision instruments and solutions. His work at Mettler-Toledo AG has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in dosage-dispensing technology.

Collaborations

Throughout his career, Marc has collaborated with talented individuals such as Paul Luechinger and Siegfried Gluvakov. These collaborations have fostered an environment of innovation and creativity, leading to the development of cutting-edge technologies.

Conclusion

Marc Bloechlinger exemplifies the spirit of innovation in the field of dosage-dispensing technology. His contributions through patents and collaborations continue to influence the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…